Regarding Prostate-Specific Antigen: Let's Not Shoot the Messenger

    October 2011 in “ QJM ”
    Mark R. Goldstein, Luca Mascitelli
    Studysummary This study found that 5α-reductase inhibitors significantly reduced low-grade prostate cancer incidence in men but nearly doubled the incidence of high-grade prostate cancers.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on academic.oup.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. The Risks and Benefits of 5α-Reductase Inhibitors for Prostate Cancer Prevention New England journal of medicine/˜The œNew England journal of medicine · 2011
    2. Proscar and Propecia: A Therapeutic Perspective The Journal of Clinical Endocrinology & Metabolism · 2004